Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
After more than twenty-five years of negotiations, the European Union and the Mercosur countries — Brazil, Argentina, Uruguay and Paraguay — finalized their trade agreement. Provisionally applied since 1 May 2026, the agreement marks a major step in economic relations between Europe and South America. For European companies in cosmetics, fragrance and home fragrance, the issue is twofold: benefiting from progressively improved commercial access to high-potential markets, while continuing to comply with regulatory requirements that remain largely national. Although the EU–Mercosur agreement creates new opportunities, it does not remove product registration obligations, labelling requirements or the need for a local responsible party in the countries concerned. For European brands, success will depend not only on commercial strategy, but also on early regulatory planning.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
New opinions have been issued on the CLP classification of silanamine, a biocidal product that is believed to introduce inhalation hazards. We provide an update on the current status of silanamine in this article.
As graphene is a material with very specific properties, it has many commercial applications. However, since 2021, concerns have been raised about its toxicity. EcoMundo reviews for you what you need to know about graphene, as well as its oxidized form.
Learn about the requirements for preparing a Safety Data Sheet (SDS) in compliance with Annex II of REACH. Discover the changes introduced by the European Commission and the 16 sections of an SDS.
Learn about the regulations impacting homecare products such as CLP, Detergents, BPR, IFRA, and other standards. Understand the requirements for compliance and how to navigate the complex regulatory landscape for homecare products.
The use of hexavalent chromium in surface treatments must be replaced by another substance. Indeed, Cr6+ chromium compounds have been included in Annex XIV of REACH due to their mutagenic and carcinogenic properties. An alternative seems to be trivalent chromium compounds such as chromium acetate, chromium oxide, dichromium trisulfate and chromium trinitrate.
If the Commission agrees with the Biocidal Products Committee (BPC) statement on iodine, it will no longer be approved for use in the EU (unless an exemption is obtained).
